Skip to main navigation

Home
About
Pipeline
Science
For Patients
Jobs
Investors
Contact

News Releases

Site - News & Events

News Releases
Presentations and Events

News Releases

Year

Jun 25, 2020

Leap Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Jun 22, 2020

Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants

Jun 18, 2020

Leap Therapeutics Announces Pricing of $45 Million of Common Stock and Pre-Funded Warrants

Jun 17, 2020

Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Jun 11, 2020

Leap Therapeutics Announces Orphan Drug Designation of DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer

Jun 11, 2020

Leap Therapeutics Announces Changes to Virtual Format and Time for 2020 Annual Meeting of Stockholders

May 14, 2020

Leap Therapeutics Reports First Quarter 2020 Financial Results

Apr 23, 2020

Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy and Paclitaxel Combination In Gynecologic Cancers

Mar 18, 2020

Leap Therapeutics Announces Executive Leadership Changes

Mar 16, 2020

Leap Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

Pagination

Current page 1
Page 2
Next page
Last page

Print Page

Email Alerts

Contact Us

© 2020 Leap Therapeutics, Inc.
All Rights Reserved
Terms of Use
Privacy Policy